An HIV Vaccine for South-East Asia—Opportunities and Challenges

Recent advances in HIV vaccine development along with a better understanding of the immune correlates of risk have emerged from the RV144 efficacy trial conducted in Thailand. Epidemiological data suggest that CRF01_AE is still predominant in South-East Asia and is spreading in China with a growing...

Full description

Bibliographic Details
Main Authors: Jerome H. Kim, Jean-Louis Excler, Robert J. O'Connell, Supachai Rerks-Ngarm, Punnee Pitisuttithum
Format: Article
Language:English
Published: MDPI AG 2013-08-01
Series:Vaccines
Subjects:
Online Access:http://www.mdpi.com/2076-393X/1/3/348